Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies

Clinical trial NCT02179359 · TERMINATED

Trial details

NCT number: NCT02179359
Sponsor: Masonic Cancer Center, University of Minnesota
Status: TERMINATED
Phase: Not Applicable
Study type: INTERVENTIONAL

Sickle Cell Disease Transfusion Dependent Alpha- or Beta- Thalassemia Diamond Blackfan Anemia Paroxysmal Nocturnal Hemoglobinuria Glanzmann Thrombasthenia Severe Congenital Neutropenia Shwachman-Diamond Syndrome Non-Malignant Hematologic Disorders

Start date: 2014-09-02
Primary completion: 2024-11-21
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.